News 2017-03-24
ISR has prepared a company description prior to listing on Nasdaq First North on March 24, 2017, which has been approved by Nasdaq First North.
Files & documents
© ISR Immune System Regulation Holding AB (publ). All rights reserved.
Retzius väg 11
SE-171 65 Solna, Sweden
Email: info@israb.se
Phone: +46 705 42 79 39